Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Does Intravitreal Injection of Triamcinolone Acetonide Impairs the Adrenal Function

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
avraham ishay, HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
NCT00561236
First received: November 18, 2007
Last updated: September 7, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2008
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)